Statistics

Total Visits

Views
Real-world use of cabazitaxel plus prednisone in patients with metastatic castration-resistant prostate cancer (mcrpc) PREVIOUSLY TREATED WITH DOCETAXEL: REGIONAL ANALYSIS23

Select a period of time:

Number of views in the range

Views
Real-world use of cabazitaxel plus prednisone in patients with metastatic castration-resistant prostate cancer (mcrpc) PREVIOUSLY TREATED WITH DOCETAXEL: REGIONAL ANALYSIS19

Views

Views
January 20250
February 20250
March 202515
April 20252
May 20252
June 20250
July 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
Spain2
Brazil1
United States1
 

Top cities views

Views
Council Bluffs1
Itapajé1
Madrid1